Professor of Medicine
Pulmonology
Dr. Robert A. Sandhaus, MD
|
|
Give Review
Doctor Robert A. Sandhaus, MD is an expert in the field of Pulmonology. He graduated from Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received awards:"Clinical Investigator Award Grant", "Member" and "Award for meritorious research". Robert A. Sandhaus, MD is a published doctor and has 33 publications published. The lastest was: 'Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD.' Robert Sandhaus is registered with Medicare and accepts Medicare payments.
Publications
- Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD.
- The Social Environment and Illness Uncertainty in Chronic Obstructive Pulmonary Disease.
- Biochemical Efficacy and Safety of a New, Ready-to-Use, Liquid Alpha-1-Proteinase Inhibitor, GLASSIA (Alpha-Proteinase Inhibitor (Human), Intravenous).
- Prospective Impact of Illness Uncertainty on Outcomes in Chronic Lung Disease.
- The prospective association of perceived criticism with dyspnea in Chronic lung disease.
- The impact of age on outcomes in Chronic obstructive pulmonary disease differs by relationship status.
- Differences in Adjustment between Individuals with Alpha-1 Antitrypsin Deficiency (AATD)-Associated COPD and Non-AATD COPD.
- Introduction to the 50th anniversary of the description of alpha-1 antitrypsin deficiency.
- Neutrophil elastase-mediated lung Disease.
- The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction.
- Alcohol use predicts ER visits in individuals with alpha-1 antitrypsin deficiency (AATD) associated COPD.
- Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency.
- Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency.
- Phase 2 Clinical Trial of a Recombinant Adeno-associated Virus Vector Expressing Alpha 1 Antitrypsin: Interim Results.
- Pharmacokinetic comparability of Prolastin(R)-C to Prolastin(R) in alpha(1)-antitrypsin deficiency: a randomized study.
- Alpha-1 antitrypsin deficiency: whom to test, whom to treat?
- Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. 2003.
- Quantitative airway assessment on computed tomography in patients with alpha1-antitrypsin deficiency.
- Augmentation therapy in alpha-1 antitrypsin deficiency.
- Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy.
- Clinical practice. Alpha1-antitrypsin deficiency.
- Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years.
- Effects of a Disease management program in individuals with alpha-1 antitrypsin deficiency.
- alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.
- IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
- Influenza vaccination in subjects with alpha1-antitrypsin deficiency.
- Impact of preservation solution on the extent of blood-air barrier damage and edema formation in experimental Lung transplantation.
- Alpha-1 antitrypsin deficiency: doing the right thing (or start kissing those frogs).
- Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem.
- Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003.
- Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.
- Might your respiratory patient have alpha-1 antitrypsin deficiency?
Schools
Stony Brook Univ Health Sciences Center School Of Medicine
Beth Israel Hospital
University Calif
Procedures Preformed
- Continuous Positive Airway Pressure (CPAP)
Conditions Treated
- Acute Pharyngitis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Whole Health Colorado Front Range
- American Enterprise Group
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Humana
- Kaiser Permanente
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Clinical Investigator Award Grant
- Member
- Award for meritorious research
Education
-
Beth Israel Deaconess Medical Center -
Harvard Medical School -
Stony Brook University School of Medicine -
National Institutes of Health Clinical Center
Hospital
-
National Jewish Health
Drug Facts
| NPI NUMBER | 1093884652 | |
| NPPES Provider LastName | SANDHAUS | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 802062761 | |
| NPPES Provider State | CO | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 275.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093884652 |
| Last Name Of The Provider | SANDHAUS |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Nabeel Y. Hamzeh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip R. Corsello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth E. Lyn-Kew, MD |
|
|
Dr. Robert J. Mason, MD |
|
Dr. James Crapo, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael J. Gerber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James P. Woodrow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John P. Wilkins, MD |